Orthofix Names Kimberley Elting as New Orthopedics President

Orthofix has named a new president for its global orthopedics business, effective today. Chief legal and development officer Kimberley Elting will lead the business, succeeding Paul Gonsalves who is leaving the company to pursue other opportunities.
 
“With more than 25 years in the medical device space, a track record of success at Orthofix, and a demonstrated passion for our Orthopedics business, Kim will bring strong leadership and meaningful perspective to this business,” Orthofix president and CEO Jon Serbousek told the press. “We have made significant investments to build the Orthopedics Business unit and we feel confident that she is the right person to lead this team to continue to drive growth in this sector of our business.”
 
Elting’s leadership has thus far resulted in successful acquisitions to expand Orthofix’s portfolio, including the M6-C artificial cervical disc, Fitbone internal limb lengthening system, biologics expansions, and investments in nView Medical and Neo Medical.
 
“The Orthopedics business was the foundation for Orthofix over forty years ago when this company was started in Verona, Italy, and it has a long history of providing meaningful products and life-changing patient solutions to orthopedic surgeons world-wide,” said Elting. “I look forward to working with this talented team as we continue to innovate and bring to market differentiated products and solutions for pediatric and adult deformity correction and limb reconstruction, helping deliver on our commitment to improve patient mobility.”
 
Elting joined Orthofix leadership as chief legal officer in 2016, named chief legal and administrative officer in 2017, then chef legal and development officer in 2020. Prior to Orthofix, she was TriVasvular Technologies’ general counsel and VP of corporate affairs. She also served as general counsel and VP of HR and health policy for St. Jude Medical’s neuromodulation business. She was previously a partner at the Jones Day law firm.